Wednesday, February 10, 2010, 2:54pm SGT - The Singapore stock market closes in 2 hours and 6 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Rockwell Medical Technologies Inc. (RMTI)

At 5:00AM SGT: 7.27 USD  Up 0.04 (0.55%)  
 MORE ON RMTI 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Rockwell Medical Technologies, (NGM:RMTI) Delayed quote dataEdit
After Hours: 7.27 0.00 (0.00%) as of 5:34am SGT on 02/10/10
Last Trade:7.27 USD
Trade Time:5:00AM SGT
Change:Up 0.04 (0.55%)
Prev Close:7.23
Open:7.50
Bid:6.55 x 300
Ask:8.54 x 600
1y Target Est:11.50
Day's Range:7.23 - 7.31
52wk Range:2.56 - 9.39
Volume:22,314
Avg Vol (3m):56,461.9
Market Cap:124.03M
P/E (ttm):N/A
EPS (ttm):-0.57
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add RMTI to Portfolio   Download Data

 HEADLINES 
•ROCKWELL MEDICAL TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Jan 21)
•The Best Investing Ideas in Health Care
at Motley Fool (Wed, Dec 16)
•Coverage initiated on Rockwell Medical Tech. by JMP Securities
Briefing.com (Thu, Dec 10)
•ROCKWELL MEDICAL TECHNOLOGIES INC Financials
EDGAR Online Financials (Wed, Nov 11)
•ROCKWELL MEDICAL TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
EDGAR Online (Wed, Nov 4)
•Rockwell Medical Reports Third Quarter Results; Expanded Gross Profit Margins
GlobeNewswire (Wed, Nov 4)
•Rockwell Medical Presents New Data on Proprietary Iron-Delivery Drug SFP at American Society of Nephrology Annual Meeting
Marketwire (Mon, Nov 2)
•Rockwell Medical Completes SFP Phase IIb Clinical Study
GlobeNewswire (Thu, Oct 29)
•Rockwell Medical Announces New Corporate Name
Marketwire (Tue, Oct 27)
•Rockwell Medical Schedules Investor Conference Call
GlobeNewswire (Mon, Oct 26)
More Headlines for RMTI...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.42
EPS Est (in 2 years) (Dec-10) :-0.42
Avg Rec (current)*:1.5
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Rockwell Medical Technologies, Inc., an integrated biopharmaceutical company, offers products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices